Evolent Health Inc. is a leading healthcare technology and services company that partners with healthcare organizations to improve their clinical and financial performance
By providing innovative solutions, including data-driven insights, care management tools, and population health strategies, Evolent Health helps organizations transition to value-based care models. Their integrated approach aims to enhance patient outcomes, optimize resource utilization, and empower healthcare providers through streamlined operations and advanced analytics. The company focuses on transforming the healthcare landscape by enabling more effective delivery of healthcare services and fostering better health experiences for patients.
Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Healthcare solutions company Evolent Health (NYSEEVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue guidance of $455 million underwhelmed, coming in 22.7% below analysts’ estimates. Its non-GAAP loss of $0.02 per share was significantly below analysts’ consensus estimates.
Health insurance provider Elevance Health (NYSEEVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus estimates.
